Maegim

Stock search

Search by company name, 6-digit code, or Korean initials (e.g. ㅅㅅㅈㅈ)

☆한국어

GeneBioTechCo.,Ltd.

진바이오텍086060KOSDAQSector: Retail & Consumer Services
₩4,8650.31%Market cap ₩41.9BAs of Sep 4, 2026 close · updated once daily
Market cap
₩41.9B
#1230 in KOSDAQ
11.1x
Sector median 11.0x (profitable cos.)
0.76x
Sector median 0.64x
1.2%
Sector median 0.0%
A
Grade A66.6 ptsTop 18% of 2,522 graded stocksMethodology v2.0
Financial strength
74.8/100
Growth momentum
68.2/100
Price attractiveness
56.0/100
Shareholder Return
67.0/100

As of Sep 4, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

How to read this grade
SACurrentBCDF

Toward S means a higher total-score band; toward F, a lower band. Badges are distinguished by ink intensity and shape (fill, outline, dashed) — never by hue.

Maegim maps a total score — built from sector-relative percentile scoring — onto fixed, predefined thresholds to assign one of six bands, S to F. This stock is scored by the same formula as all 2,522 graded stocks and is currently in band A with a total score of 66.6 points.

How grades are computed →What grades do and don’t mean →What the grade does not reflect →

Position within sector

Mechanically selected indicators in the top or bottom 30% of sector percentiles · among 167 stocks in Retail & Consumer Services

1-year closing price

Loading closing price history…
 
Low ₩3,600High ₩5,230
Latest close
Price change by period
1W
2.50%
1M
1.50%
3M
25.80%
1Y
9.20%

As of the Sep 4, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

1

Financial strength

74.8/100
How much debt does it carry relative to equity?
37.5%
Sector median 78.3%
Sector lowhighTop 28% in sector
Can it cover what's due within a year?
348.2%
Sector median 147.9%
Sector lowhighTop 18.4% in sector
How much of revenue becomes profit?
4.3%
Sector median 1.3%
Sector lowhighTop 28.6% in sector
How much did it earn on its own capital?
6.9%
Sector median 2.1%
Sector lowhighTop 25.8% in sector

Source filing: annual report (consolidated) — view original ↗

2

Growth momentum

68.2/100
How much did revenue grow in a year?
9.4%
Sector median 1.0%
Sector lowhighTop 24.1% in sector
Has it grown steadily over three years?
3.1%
Sector median -1.5%
Sector lowhighTop 35.7% in sector
Did core profits grow in a year?
2.0%
Sector median 7.8%
Sector lowhighBottom 46.6% in sector
Are core profits higher than three years ago?
134.8%
Sector median 3.9%
Sector lowhighTop 13.9% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (consolidated) — view original ↗

3

Price attractiveness

56.0/100
Is the price expensive relative to earnings?
11.1x
Sector median P/E of profitable peers 11.0x · 39% loss-making
Sector lowhighTop 30.6% in sector
Is the price expensive relative to book value?
0.76x
Sector median 0.64x
Sector lowhighBottom 42.5% in sector

Valuation uses the Sep 4, 2026 close and market cap

4

Shareholder Return

Single-indicator axis67.0/100
Does the company actually pay dividends?
1.2%
Sector median 0.0%
Sector lowhighTop 33% in sector

Dividend per share (annual)

Cash dividend per common share as stated in annual reports. ₩0 means no dividend that year.

Dividends & treasury shares

Total cash dividends (FY2025)
₩431M
Cash payout ratio, consolidated (FY2025)
11.4%

Source: annual report (DART) — dividend allocation & total shares

Source filing: annual report (consolidated) — view original ↗

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 7, 2026

Of 9 items: 7 met · 1 not met · 1 not computable

Not metMetNot computable

Positive net income
Whether net income (attributable to owners where available) is above zero.
Met
₩3.8B
Positive operating cash flow
Whether cash flow from operations is above zero.
Met
₩7.6B
Return on assets up
Whether net income over beginning total assets rose from the prior year.
Met
4.3% → 5.3%
Operating cash flow exceeds net income
Whether operating cash flow is greater than net income.
Met
₩7.6B vs ₩3.8B
Liabilities-to-assets ratio down
Whether total liabilities as a share of total assets fell from the prior year.
Met
29.2% → 27.3%
Current ratio up
Whether current assets over current liabilities rose from the prior year.
Met
304.0% → 348.2%
Shares outstanding not increased
Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.
Not computable

Not computed — share count data is unavailable

Operating margin up
Whether operating income over revenue rose from the prior year.
Not met
4.6% → 4.3%
Asset turnover up
Whether revenue over beginning total assets rose from the prior year.
Met
1.257x → 1.261x

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (consolidated) — view original ↗

Grade change history

Jul 23, 2026A

Methodology version change (v2.0 applied)

Jul 15, 2026AVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Recent filings for this stock

Last 120 days · monitored filing types only
Periodic report filedAug 14, 2026Source ↗
Periodic report filedMay 14, 2026Source ↗

View in the filings calendar →